Pulmonary rehabilitation in patients diagnosed with non-IPF-fibrosing interstitial lung disease receiving antifibrotic therapy

被引：1
|
作者：
Satar, Seher [1 ]
Sahin, Mustafa Engin [1 ]
Yesiloz, Zeynep [1 ]
Ergun, Pinar [1 ]
机构：
[1] Turkish Thorac Soc, Ankara, Turkiye
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA3187
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
    Sebastiano Emanuele Torrisi
    Nicolas Kahn
    Julia Wälscher
    Nilab Sarmand
    Markus Polke
    Kehler Lars
    Monika Eichinger
    Claus Peter Heussel
    Stefano Palmucci
    Francesca Maria Sambataro
    Gianluca Sambataro
    Domenico Sambataro
    Carlo Vancheri
    Michael Kreuter
    BMC Pulmonary Medicine, 19
  • [2] Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases
    Torrisi, Sebastiano Emanuele
    Kahn, Nicolas
    Waelscher, Julia
    Sarmand, Nilab
    Polke, Markus
    Lars, Kehler
    Eichinger, Monika
    Heussel, Claus Peter
    Palmucci, Stefano
    Sambataro, Francesca Maria
    Sambataro, Gianluca
    Sambataro, Domenico
    Vancheri, Carlo
    Kreuter, Michael
    BMC PULMONARY MEDICINE, 2019, 19 (01)
  • [3] Possible Value of Antifibrotic Drugs in Patients with Progressive Fibrosing Non-IPF Interstitial Lung Diseases
    Torrisi, S.
    Kahn, N. C.
    Waelscher, J.
    Sarmand, N.
    Polke, M.
    Heussel, C.
    Palmucci, S.
    Sambataro, G.
    Vancheri, C.
    Kreuter, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [4] The extended utility of antifibrotic therapy in progressive fibrosing interstitial lung disease
    Sarkar, Paroma
    Avram, Cristina
    Chaudhuri, Nazia
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2020, 14 (10) : 1001 - 1008
  • [5] The benefits of pulmonary rehabilitation in patients with diagnosed interstitial lung disease
    Lovy, Richard
    VanderRoest, Will
    Matheny, Shane
    Taweel, Jamie
    Meek, Johnny
    CHEST, 2007, 132 (04) : 583S - 583S
  • [6] Current Treatment of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease
    Opuni, Kwabena
    Kreuter, Michael
    Quaresma, Manuel
    Wijsenbeek, Marlies
    Olson, Amy
    Fischer, Aryeh
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 782 - 782
  • [7] Current Treatment of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease
    Kreuter, M.
    Olson, A.
    Fischer, A.
    Bendstrup, E.
    Mounir, B.
    Zouad-Lejour, L.
    Wells, C. D.
    Quaresma, M.
    Wijsenbeek, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [8] Efficacy of Antifibrotic Treatments in Patients with Progressive Fibrosing Interstitial Lung Disease
    Sugino, K.
    Ono, H.
    Saito, M.
    Ando, M.
    Tsuboi, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [9] Antifibrotic therapy - new approvals for non-IPF interstitial lung diseases
    Markart, Philipp
    Drakopanagiotakis, Fotios
    Wygrecka, Malgorzata
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (03) : 181 - 184
  • [10] Antifibrotic Therapy in Fibrosing Interstitial Lung Disease: A Retrospective Analysis at a Tertiary Referral Institution
    Koppurapu, V. S.
    Zemkova, Y.
    Barber, D.
    Shin, K.
    Laroia, A.
    Lee, C.
    Ussavarungsi, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
12345